Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
15.54
-0.24 (-1.52%)
May 13, 2025, 4:00 PM - Market closed

Tourmaline Bio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
35.3330.51140.738.260.15
Short-Term Investments
213.98227.862.23--
Cash & Short-Term Investments
249.31258.3202.958.260.15
Cash Growth
-14.93%27.27%2357.63%5405.33%-
Prepaid Expenses
8.8410.545.920.05-
Total Current Assets
258.14268.84208.878.310.15
Property, Plant & Equipment
0.230.270.450.57-
Long-Term Investments
2636.63---
Other Long-Term Assets
3.133.260.970.22-
Total Assets
287.5309210.39.10.15
Accounts Payable
2.243.581.070.40.19
Accrued Expenses
5.195.13.710.80.03
Short-Term Debt
----0.15
Current Portion of Leases
0.20.230.220.16-
Total Current Liabilities
7.628.9151.360.38
Long-Term Leases
-0.020.190.34-
Other Long-Term Liabilities
0.010.020.06--
Total Liabilities
7.648.955.251.710.38
Common Stock
000--
Additional Paid-In Capital
437.86435.01267.020.2-
Retained Earnings
-158.23-135.26-62.05-19.93-0.23
Comprehensive Income & Other
0.230.30.07--
Total Common Equity
279.86300.05205.04-19.73-0.23
Shareholders' Equity
279.86300.05205.047.39-0.23
Total Liabilities & Equity
287.5309210.39.10.15
Total Debt
0.20.240.420.50.15
Net Cash (Debt)
249.11258.06202.547.75-
Net Cash Growth
-14.89%27.41%2512.02%--
Net Cash Per Share
9.6710.1842.678.84-
Filing Date Shares Outstanding
25.6925.6925.6510.8810.88
Total Common Shares Outstanding
25.6825.6220.3410.8810.88
Working Capital
250.52259.93203.876.95-0.23
Book Value Per Share
10.9011.7110.08-1.81-0.02
Tangible Book Value
279.86300.05205.04-19.73-0.23
Tangible Book Value Per Share
10.9011.7110.08-1.81-0.02
Machinery
-0.060.050.02-
Leasehold Improvements
-0.070.070.06-
Updated May 2, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q